Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
An approved drug label with formal contraindications does not yet exist for CagriSema
According to FDA safety communications, patients should ask their provider or compounder how to measure and administer the intended dose
Discretionary categoriesparticularly salty snacks and chipsare likely to face the greatest pressure
Weeks 1-4: 2mg once weekly Weeks 5-8: 4mg once weekly Weeks 9-12: 8mg once weekly Week 13 onward: 12mg once weekly (maintenance) Total escalation time spans 12 weeks, slower than some competitors but necessary given the triple-receptor mechanism
Quick Answer: Most patients on tirzepatide experience reduced appetite, early fullness after meals, and gastrointestinal effects like nausea (15-46%), which typically diminish within 4-8 weeks as the body adjusts to treatment
